Forza Wealth Management’s Novo Nordisk NVO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$382K Hold
7,966
0.12% 150
2026
Q1
$293K Hold
7,966
0.1% 163
2025
Q4
$405K Sell
7,966
-2,500
-24% -$128K 0.15% 137
2025
Q3
$581K Sell
10,466
-1,500
-13% -$87.8K 0.22% 107
2025
Q2
$826K Sell
11,966
-400
-3% -$27.2K 0.34% 78
2025
Q1
$859K Sell
12,366
-300
-2% -$24.8K 0.39% 68
2024
Q4
$1.09M Sell
12,666
-260
-2% -$28.1K 0.5% 50
2024
Q3
$1.54M Hold
12,926
0.7% 40
2024
Q2
$1.85M Sell
12,926
-750
-5% -$99.4K 0.95% 31
2024
Q1
$1.76M Hold
13,676
0.91% 30
2023
Q4
$1.41M Sell
13,676
-7,900
-37% -$781K 0.78% 38
2023
Q3
$1.96M Sell
21,576
-200
-0.9% -$17.6K 1.01% 26
2023
Q2
$1.76M Buy
21,776
+400
+2% +$32.7K 0.89% 27
2023
Q1
$1.7M Buy
21,376
+15,006
+236% +$1.06M 0.88% 26
2022
Q4
$431K Buy
+6,370
New +$373K 0.29% 94

Other funds holding NVO

Forza Wealth Management's NVO Position: Q2 2026 in Review

Forza Wealth Management held its Novo Nordisk (NVO) position steady in Q2 2026 at 7,966 shares worth $382K. The position accounts for 0.12% of the portfolio, ranked #150.

Forza Wealth Management first reported a position in NVO in Q4 2022 and has held it in 15 quarters since. The position peaked at $1.96M in Q3 2023. 269 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Forza Wealth Management held 7,966 shares of Novo Nordisk worth $382K as of Q2 2026.
  • Forza Wealth Management left its Novo Nordisk share count unchanged in Q2 2026.
  • Novo Nordisk made up 0.12% of Forza Wealth Management's portfolio in Q2 2026, its #150 holding.
  • Forza Wealth Management first reported a position in Novo Nordisk in Q4 2022 and has held it in 15 quarters since.
  • Forza Wealth Management's Novo Nordisk position peaked at $1.96M in Q3 2023.
  • 269 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Forza Wealth Management's 13F filing for Q2 2026, filed 17 Jul 2026.